Literature DB >> 17763959

Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line.

Peter C Konturek1, Grzegorz Burnat, Tilman Rau, Eckhart G Hahn, Stanislaw Konturek.   

Abstract

BACKGROUND: Obesity is an important risk factor for Barrett adenocarcinoma. However, the role of adiponectin (anti-inflammatory adipokine from adipose tissue) and ghrelin (orexigenic peptide gastric origin) on the progression of Barrett's carcinogenesis has not been investigated so far. The aim of the present study was: (1) to compare the expression of adiponectin and ghrelin receptors in Barrett's esophagus and in normal squamous epithelium; (2) to assess the effect of adiponectin and ghrelin on apoptosis in Barrett's adenocarcinoma cells in vitro; and (3) to investigate the effect of ghrelin on IL-1beta and COX-2 expression in OE-19 cells incubated with TNFalpha.
METHODS: The expression of ghrelin and adiponectin receptors (GHS-R1a, Adipo-R1, Adipo R-2) in biopsies from Barrett's esophagus and in Barrett's adenocarcinoma cell line OE-19 was assessed by quantitative RT-PCR (qRT-PCR). The OE-19 cells were also incubated with adiponectin (5-10 microg/ml), and the apoptosis and proliferation were assessed by FACS and MTT assays. Additionally, effects of adiponectin on the mRNA and protein expression of proapoptotic Bax and antiapoptotic Bcl-2 were assessed by RT-PCR and Western blot, respectively. In two different in vitro models of esophagitis the OE-19 cells were incubated with ghrelin alone or in the presence of TNFalpha or bile acids in the normal or pulse acidified medium, and the expression of IL-1beta and COX-2 as markers for inflammation were assessed by FACS and qRT-PCR, respectively.
RESULTS: Adiponectin caused a significant increase in apoptosis, and this affect was accompanied by increased Bax and decreased Bcl-2 expression. In contrast, ghrelin had no effect on apoptosis of OE-19 cells incubated in neutral or acidified medium with or without addition of deoxycholic acid. At the mRNA level, the expression of adiponectin receptors (Adipo-R1, Adipo-R2) was decreased, and the expression of ghrelin receptor (GHS-R1a) was increased in Barrett's mucosa. Ghrelin caused a decrease in TNFalpha-induced COX-2 and IL-1beta expression in OE-19 cells.
CONCLUSION: Adiponectin and ghrelin have an inhibitory effect on Barrett's carcinogenesis by two different mechanisms: (1) by an increase in apoptosis by adiponectin, and (2) by anti-inflammatory actions of ghrelin. The decrease in levels of these two peptides in obesity may explain the progression of Barrett's carcinoma in obese individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763959     DOI: 10.1007/s10620-007-9922-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.

Authors:  M Menges; M Müller; M Zeitz
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

Review 2.  Drug insight: The functions of ghrelin and its potential as a multitherapeutic hormone.

Authors:  Masayasu Kojima; Kenji Kangawa
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-02

3.  Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects.

Authors:  Mina Suematsu; Akira Katsuki; Yasuhiro Sumida; Esteban C Gabazza; Shuichi Murashima; Kazutaka Matsumoto; Nagako Kitagawa; Hajime Akatsuka; Yasuko Hori; Kaname Nakatani; Kenji Togashi; Yutaka Yano; Yukihiko Adachi
Journal:  Eur J Endocrinol       Date:  2005-09       Impact factor: 6.664

4.  Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells.

Authors:  Marie-Noelle Dieudonne; Marianne Bussiere; Esther Dos Santos; Marie-Christine Leneveu; Yves Giudicelli; René Pecquery
Journal:  Biochem Biophys Res Commun       Date:  2006-04-27       Impact factor: 3.575

5.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

6.  The association of body mass index with Barrett's oesophagus.

Authors:  D J Stein; H B El-Serag; J Kuczynski; J R Kramer; R E Sampliner
Journal:  Aliment Pharmacol Ther       Date:  2005-11-15       Impact factor: 8.171

7.  Plasma adiponectin and gastric cancer.

Authors:  Makoto Ishikawa; Joji Kitayama; Shinsuke Kazama; Takeyuki Hiramatsu; Kenji Hatano; Hirokazu Nagawa
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

8.  Prostaglandin/cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury.

Authors:  Tomasz Brzozowski; Peter C Konturek; Zbigniew Sliwowski; Robert Pajdo; Danuta Drozdowicz; Slawomir Kwiecien; Grzegorz Burnat; Stanislaw J Konturek; Wieslaw W Pawlik
Journal:  J Pharmacol Exp Ther       Date:  2006-07-25       Impact factor: 4.030

Review 9.  Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ.

Authors:  Akio Inui; Akihiro Asakawa; Cyril Y Bowers; Giovanni Mantovani; Alessandro Laviano; Michael M Meguid; Mineko Fujimiya
Journal:  FASEB J       Date:  2004-03       Impact factor: 5.191

10.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

Authors:  Ebba Bråkenhielm; Niina Veitonmäki; Renhai Cao; Shinji Kihara; Yuji Matsuzawa; Boris Zhivotovsky; Tohru Funahashi; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  38 in total

1.  B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece.

Authors:  Maria Dalamaga; Bradley H Crotty; Jessica Fargnoli; Evangelia Papadavid; Antigoni Lekka; Maria Triantafilli; Konstantinos Karmaniolas; Ilias Migdalis; Amalia Dionyssiou-Asteriou; Christos S Mantzoros
Journal:  Cancer Causes Control       Date:  2010-05-08       Impact factor: 2.506

Review 2.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 3.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

4.  Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus.

Authors:  Joel H Rubenstein; Hal Morgenstern; Daniel McConell; James M Scheiman; Philip Schoenfeld; Henry Appelman; Laurence F McMahon; John Y Kao; Val Metko; Min Zhang; John M Inadomi
Journal:  Gastroenterology       Date:  2013-08-30       Impact factor: 22.682

5.  Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.

Authors:  Jose M Garcia; Andres E Splenser; Jennifer Kramer; Abeer Alsarraj; Stephanie Fitzgerald; David Ramsey; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

6.  Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First).

Authors:  Sri Ganeshamurthy Thrumurthy; Christopher John Lewis; Susan Pritchard; Gordon Armstrong; Stephen Edwin Arthur Attwood
Journal:  Surg Endosc       Date:  2012-01       Impact factor: 4.584

7.  Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression.

Authors:  Nir Kleinmann; Wilhelmina C M Duivenvoorden; Sarah N Hopmans; Laura K Beatty; Shengjun Qiao; Daniel Gallino; Sarka Lhotak; Dean Daya; Athanasios Paschos; Richard C Austin; Jehonathan H Pinthus
Journal:  Clin Exp Metastasis       Date:  2013-10-05       Impact factor: 5.150

8.  Adiponectin modulates DCA-induced inflammation via the ROS/NF-κ B signaling pathway in esophageal adenocarcinoma cells.

Authors:  Rong Zhang; Xiaoran Yin; Haitao Shi; Jie Wu; Pramod Shakya; Dong Liu; Jun Zhang
Journal:  Dig Dis Sci       Date:  2013-10-05       Impact factor: 3.199

9.  Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus.

Authors:  Brooke M Winzer; Jennifer D Paratz; Marina M Reeves; David C Whiteman
Journal:  BMC Cancer       Date:  2010-06-16       Impact factor: 4.430

Review 10.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.